AEON Biopharma, Inc. - Common Stock (AEON) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
AEON on NYSE
Shares outstanding
11,898,571
Price per share
$1.11
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
2,443,029
Total reported value
$1,667,217
% of total 13F portfolios
0%
Share change
+1,078,582
Value change
+$712,814
Number of holders
22
Price from insider filings
$1.11
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AEON Biopharma, Inc. - Common Stock (AEON) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Chernett Jorey 9.9% $564,250 1,128,500 Chernett Jorey 27 May 2025
Alta Partners LLC 2.1% -60% $192,400 -$259,078 249,870 -57% Alta Partners LLC 30 Sep 2025
Dauntless Investment Group, LLC 9.7% $44,372 108,224 Dauntless Investment Group, LLC 26 Feb 2025

As of 31 Dec 2025, 22 institutional investors reported holding 2,443,029 shares of AEON Biopharma, Inc. - Common Stock (AEON). This represents 21% of the company’s total 11,898,571 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of AEON Biopharma, Inc. - Common Stock (AEON) together control 21% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Dauntless Investment Group, LLC 18% 2,131,852 +89% 5.3% $1,324,924
VANGUARD GROUP INC 0.84% 100,333 +1.8% 0% $110,366
GEODE CAPITAL MANAGEMENT, LLC 0.51% 60,134 +28% 0% $66,146
XTX Topco Ltd 0.48% 56,852 +252% 0% $62,537
Blue Owl Capital Holdings LP 0.36% 43,395 +2.5% 0.01% $47,735
Laird Norton Wetherby Trust Company, LLC 0.13% 15,000 0% $16,500
TWO SIGMA SECURITIES, LLC 0.11% 13,180 0% $14,498
CITADEL ADVISORS LLC 0.1% 11,642 0% $12,806
UBS Group AG 0.03% 4,052 +240% 0% $4,457
BlackRock, Inc. 0.02% 2,834 0% 0% $3,117
BANK OF AMERICA CORP /DE/ 0.02% 2,382 +0.25% 0% $2,620
WOLFF WIESE MAGANA LLC 0% 567 +746% 0% $624
DUPONT CAPITAL MANAGEMENT CORP 0% 170 0% 0% $187
MORGAN STANLEY 0% 150 0% 0% $165
SBI Securities Co., Ltd. 0% 105 -0.94% 0% $116
Steward Partners Investment Advisory, LLC 0% 100 0% 0% $110
GHP Investment Advisors, Inc. 0% 95 0% 0% $105
WELLS FARGO & COMPANY/MN 0% 90 0% 0% $99
MAI Capital Management 0% 58 0% 0% $64
CIBC Private Wealth Group LLC 0% 33 0% 0% $36
METEORA CAPITAL, LLC 0% 4 0% $4
DANSKE BANK A/S 0% 1 0% 0% $1
JANE STREET GROUP, LLC 0% 0 -100% $0
StoneX Group Inc. 0% 0 -100% $0
BARCLAYS PLC 0% 0 -100% $0

Institutional Holders of AEON Biopharma, Inc. - Common Stock (AEON) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,443,029 $1,667,217 +$712,814 $1.10 22
2025 Q3 1,364,447 $1,103,333 +$78,032 $0.81 21
2025 Q2 1,271,217 $585,730 -$147,232 $0.76 18
2025 Q1 1,526,776 $884,785 +$884,785 $0.58 15